Apira Science announced that it has received approval from the Federal Commission for Protection against Health Risks (COFEPRIS) to sell and distribute the iGrow Hair Growth System throughout Mexico, an emerging and rapidly growing aesthetic market.
As the 40th international market to receive the low-level laser therapy (LLLT) hair growth device, Mexico represents the latest step in Apira’s continuing global expansion to meet worldwide demand for a simple, effective, and safe solution to hair loss.
The current market for LLLT products is more than $1.6 billion and is expected to reach $2.5 billion in the next five years.
Mexico joins a growing list of countries where the iGrow is now, or will soon be available, including all 28 European Union nations as well as Canada, Hong Kong, China, Thailand, United Arab Emirates, Singapore, Malaysia, Peru, Taiwan, Vietnam, and Turkey.
"Genetic-based hair thinning and loss (pattern baldness) is a widespread condition that affects men and women of all ages and nationalities," said Nicholas Brox, president and CEO of Apira. "With the introduction of the iGrow to the Mexican marketplace, individuals suffering from pattern baldness (Androgenetic Alopecia) will now be able to address and remedy hair thinning and loss effectively and conveniently, in the comfort of their own homes."
The iGrow Hair Growth System is an innovative, safe, and effective hands-free LLLT hair growth device cleared by the FDA for at-home use. Its patented red light technology, which consists of a highly productive combination of red laser and LED diodes, re-energizes cells at the follicle level, effectively regrowing thicker, fuller, and healthier hair. In clinical studies, the iGrow increased hair growth 39 percent after 16 weeks of therapy, and nearly doubled total hair growth 10 weeks faster than hand-held laser combs and brushes.